1. Home
  2. MYO

as of 12-17-2025 3:57pm EST

$0.92
$0.12
-11.54%
Stocks Health Care Industrial Specialties Nasdaq

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Chart Type:
Time Range:
Founded: 2004 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 33.2M IPO Year: 2017
Target Price: $7.67 AVG Volume (30 days): 818.8K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.29 EPS Growth: N/A
52 Week Low/High: $0.71 - $7.17 Next Earning Date: 11-10-2025
Revenue: $41,643,203 Revenue Growth: 65.00%
Revenue Growth (this year): 24.07% Revenue Growth (next year): 17.48%

Stock Insider Trading Activity of Myomo Inc. (MYO)

Buy
MYO Nov 21, 2025

Avg Cost/Share

$0.72

Shares

2,535

Total Value

$1,825.20

Owned After

481,857

SEC Form 4

Buy
MYO Nov 20, 2025

Avg Cost/Share

$0.72

Shares

4,902

Total Value

$3,529.44

Owned After

481,857

SEC Form 4

Share on Social Networks: